ARK Investment Management - RECURSION PHARMACEUTICALS IN ownership

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 128 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 1.27 and the average weighting 1.8%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of RECURSION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$52,605,973
+48.6%
6,876,598
+45.1%
0.40%
+71.8%
Q2 2023$35,396,723
+48.4%
4,738,517
+32.5%
0.23%
+42.7%
Q1 2023$23,857,670
-0.2%
3,576,862
+15.4%
0.16%
-20.8%
Q4 2022$23,897,068
-33.2%
3,099,490
-7.7%
0.21%
-16.9%
Q3 2022$35,748,000
+113.8%
3,359,811
+23.0%
0.25%
+151.5%
Q2 2022$16,720,000
-17.4%
2,732,087
-3.4%
0.10%
+17.9%
Q1 2022$20,242,000
-47.1%
2,827,163
+26.7%
0.08%
-27.6%
Q4 2021$38,234,000
-35.9%
2,232,013
-13.9%
0.12%
-18.9%
Q3 2021$59,684,000
-31.3%
2,593,836
+9.0%
0.14%
-11.7%
Q2 2021$86,822,0002,378,6750.16%
Other shareholders
RECURSION PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Kinnevik AB (publ) 10,405,668$79,603,360100.00%
Data Collective IV GP, LLC 5,941,120$45,449,56843.00%
MIC Capital Management UK LLP 8,451,758$64,655,95214.74%
MV Management XI, L.L.C. 788,762$6,034,02910.04%
ArchPoint Investors 1,047,386$8,012,5033.06%
Connective Portfolio Management, LLC 33,000$252,0000.77%
PLATINUM INVESTMENT MANAGEMENT LTD 2,335,132$17,863,7600.70%
Diametric Capital, LP 136,331$1,042,9320.44%
ARK Investment Management 6,876,598$52,605,9730.40%
ALLEN OPERATIONS LLC 217,657$1,665,0760.37%
View complete list of RECURSION PHARMACEUTICALS IN shareholders